Certain Dermoscopic Structures Linked to Melanoma Detection
WEDNESDAY, Aug. 4, 2021 -- Certain dermoscopic structures associated with melanoma detection may have diagnostic importance, including shiny white structures, pseudopods, and blue-white veil, according to a systematic review and meta-analysis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 4, 2021 Category: Pharmaceuticals Source Type: news

New Long-term Melanoma Data'Clearly Favor' IPI/NIVO New Long-term Melanoma Data'Clearly Favor' IPI/NIVO
Dr Jeffrey Weber discusses long-term follow-up data presented at ASCO 2021.Medscape Oncology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 3, 2021 Category: Radiology Tags: Hematology-Oncology Commentary Source Type: news

US FDA grants Priority Review to Roche ’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
Basel, 3 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer (NSCLC) whose tumours express PD-L1≥1%, as determined by an FDA-appro ved test. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, which aims to explore a more efficient review process to ensure safe and ef...
Source: Roche Media News - August 3, 2021 Category: Pharmaceuticals Source Type: news

US FDA grants Priority Review to Roche ’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
Basel, 3 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer (NSCLC) whose tumours express PD-L1≥1%, as determined by an FDA-appro ved test. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, which aims to explore a more efficient review process to ensure safe and ef...
Source: Roche Investor Update - August 3, 2021 Category: Pharmaceuticals Source Type: news

RNA modifications in skin cancer focus of Keystone Lecture
In NIEHS-sponsored talk, Yu-Ying He, Ph.D., suggested RNA modifications are crucial players in regulating gene-environment interactions. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - August 3, 2021 Category: Environmental Health Source Type: news

Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
DUBLIN, Aug. 2, 2021 -- (Healthcare Sales & Marketing Network) -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to nemvaleukin alfa (nemvaleukin), the company's novel, inves... Biopharmaceuticals, Oncology, FDA Alkermes, nemvaleukin, mucosal melanoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 2, 2021 Category: Pharmaceuticals Source Type: news

Almost Every Doctor Recommends Sunscreen. So Why Don ’t We Know More About Its Safety?
Each year, as Memorial Day approaches, Holly Thaggard braces herself for the headlines. About how sunscreen may be damaging coral reefs. About the possible flammability of spray-on sunscreen. Headlines—as there were this year—about how sunscreen contains chemicals that could harm your health. “This has happened every single year for the last decade of my life,” says Thaggard, founder of Texas-based Supergoop, a sunscreen company that brands itself as reef-safe and free of hundreds of potentially problematic ingredients. This year, the is-sunscreen-dangerous news cycle started in May, when Valisure, ...
Source: TIME: Health - August 2, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Public Health Source Type: news

Take This Refresher on Skin Safety in Summer Sun
SUNDAY, Aug. 1, 2021 -- Sun protection is essential as you enjoy the outdoors this summer, a skin expert stresses. " Skin cancer is the most common cancer in humans so it's important that we do what we can to protect ourselves, " Dr. Ida Orengo, a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 1, 2021 Category: General Medicine Source Type: news

Skin cancer warning: Expert divulges key decade you need to be most vigilant
SKIN cancer expert Laura Harker - the lead screening nurse at The Mole Clinic - spoke exclusively to Express.co.uk about identifying cancerous lesions. Considering new moles can develop throughout a lifetime, when should you be concerned? (Source: Daily Express - Health)
Source: Daily Express - Health - July 31, 2021 Category: Consumer Health News Source Type: news

What's Next After Anti-PD-1 Therapy for Melanoma Fails? What's Next After Anti-PD-1 Therapy for Melanoma Fails?
Dr Jeffrey Weber describes two studies with encouraging results for patients with advanced melanoma that has not responded to anti-PD-1 and other immunotherapies.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Eliminating RNA-binding protein improves survival in aggressive leukemia
Removing a protein that is often overexpressed in a rare and aggressive subtype of leukemia can help to slow the cancer ’s development and significantly increase the likelihood of survival, according to a study in mice led by scientists at theUCLA Jonsson Comprehensive Cancer Center.The research,published today in the journal Leukemia, could aid in the development of targeted therapies for cancers that have high levels of the RNA-binding protein IGF2BP3 — especially acute lymphoblastic and myeloid leukemias that are characterized by chromosomal rearrangements in the mixed lineage leukemia (MLL) gene.In these ML...
Source: UCLA Newsroom: Health Sciences - July 29, 2021 Category: Universities & Medical Training Source Type: news

ECU professor developing melanoma treatment nets $110K grant from NC Biotech
An ECU professor is assessing the commercial feasibility of the potential treatment for melanoma. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 22, 2021 Category: American Health Authors: Sonia Waraich Source Type: news

Antibiotics may help to treat melanoma
Some antibiotics appear to be effective against a form of skin cancer known as melanoma. Researchers at KU Leuven, Belgium, examined the effect of these antibiotics on patient-derived tumours in mice. Their findings were published in the Journal of Experimental Medicine. (Source: World Pharma News)
Source: World Pharma News - July 22, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Antibiotics may help to treat melanoma
(KU Leuven) Some antibiotics appear to be effective against a form of skin cancer known as melanoma. Researchers at KU Leuven, Belgium, examined the effect of these antibiotics on patient-derived tumours in mice. Their findings were published in the Journal of Experimental Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Risk for Psoriasis Increased for Cancer Survivors
Increased risks seen for survivors of leukemia, lymphoma, multiple myeloma, skin cancer, and lung cancer in subgroup analyses (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 21, 2021 Category: Cancer & Oncology Tags: Dermatology, Internal Medicine, Oncology, Journal, Source Type: news

Recent Trend: Melanoma Mortality Declining Rapidly Recent Trend: Melanoma Mortality Declining Rapidly
The drop in death rates has occurred despite increased incidence rates for both men and women.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 20, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

Metformin Use May Curb BCC Risk Metformin Use May Curb BCC Risk
The decrease in basal cell carcinoma (BCC) risk was seen across all metformin dosing levels, but the reason for this remains unclear.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 15, 2021 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Mayo Clinic Minute: Skin cancer concerns for people with darker skin
Skin cancer is the most common type of cancer. About 1 in 5 people in the U.S. will have skin cancer during their lives. And it affects all skin colors. Reporter Jason Howland explains in today's Mayo Clinic Minute. Watch: The Mayo Clinic Minute https://youtu.be/umD3Cqs91cY Journalists: Broadcast-quality video (1:18) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic News Network." Read the script. Forty percent of all cancers in Caucasians… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 15, 2021 Category: Databases & Libraries Source Type: news

Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA ® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene
NEW BRUNSWICK, N.J., JULY 14, 2021 – Johnson & Johnson Consumer Inc. (JJCI) is voluntarily recalling all lots of five NEUTROGENA® and AVEENO® aerosol sunscreen product lines to the consumer level. Internal testing identified low levels of benzene in some samples of the products. Consumers should stop using the affected products and follow the instructions set forth below.The only sunscreen products impacted are aerosol products, specifically: NEUTROGENA® Beach Defense® aerosol sunscreen, NEUTROGENA® Cool Dry Sport aerosol sunscreen,NEUTROGENA® Invisible Daily™ defense aerosol sunscre...
Source: Johnson and Johnson - July 14, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

NSCLC and Melanoma Lead Continuing Fall in US Cancer Death Rates NSCLC and Melanoma Lead Continuing Fall in US Cancer Death Rates
Cancer death rates in the US continue to decline overall for many common cancers in both men and women, especially non –small cell lung cancer (NSCLC) and melanoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Risk Factors for Melanoma by Anatomical Site Risk Factors for Melanoma by Anatomical Site
Differing risk factors for melanoma by anatomical site, as found in this study, suggest a dual pathway for its pathogenesis.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Melanoma of the eye: Preclinical tests show path toward treatment
(University of Alabama at Birmingham) A preclinical study offers hope for treatment of uveal melanoma, a rare and deadly cancer of the eye. A small molecule inhibitor has been identified that dampens the potent drivers of this tumor. In mouse models, the inhibitor strongly limited primary disease in the eye and metastatic tumor dissemination to the liver, and animals survived longer, without overt side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 14, 2021 Category: Cancer & Oncology Source Type: news

A new approach to metastatic melanoma discovered
(IMIM (Hospital del Mar Medical Research Institute)) Combining chemotherapy with a BRAF oncogene inhibitor proves effective at treating this disease. The study, published in the journal Oncogene, was led by researchers from the Hospital del Mar Medical Research Institute, Hospital del Mar and CIBERONC. This alternative paves the way towards a new approach for patients affected by this type of tumour, which has no cure in the most advanced stages or cases of relapse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2021 Category: International Medicine & Public Health Source Type: news

Scientist Prue Hart: ‘Sunburn causes havoc in the skin – we should avoid it’
The inflammation researcher explains the health benefits and dangers of soaking up the sunProf Prue Hart is head of the inflammation research group at the Telethon Kids Institute in Perth, Australia, which studies the beneficial effects of sunlight exposure on our health and whether these are the result of UV-induced vitamin D or other molecules produced in our skin upon exposure to sunlight.What exactly happens when the sun hits our skin?Sunlight is made up of three components: there ’s the visible light that gives colour to everything we see; infrared light, which provides the heat; and ultraviolet (UV) light, whic...
Source: Guardian Unlimited Science - July 11, 2021 Category: Science Authors: Linda Geddes Tags: Science Health Skin cancer The sun Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

U.S. Cancer Mortality Rates Down From 2014 to 2018
THURSDAY, July 8, 2021 -- Cancer death rates in the United States continued to decline overall from 2014 to 2018, with declines accelerating for lung cancer and melanoma, according to a report published online July 8 in the Journal of the National... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2021 Category: Pharmaceuticals Source Type: news

Annual Report to the Nation: Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
Overall incidence rates continue to increase in women, children and adolescents and young adults. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - July 8, 2021 Category: American Health Source Type: news

Annual report to the nation: Rapid decrease in lung cancer and melanoma deaths
(American Cancer Society) Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2021 Category: International Medicine & Public Health Source Type: news

Study identifies gut microbes associated with toxicity to combined checkpoint inhibitors in melanoma patients
(University of Texas M. D. Anderson Cancer Center) Researchers from The University of Texas MD Anderson Cancer Center found specific intestinal microbiota signatures correlate with high-grade adverse events and response to combined CTLA-4 and PD-1 blockade treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2021 Category: Cancer & Oncology Source Type: news

FDA Approves Expanded Indication for Merck ’s Keytruda (pembrolizumab) in Locally Advanced Cutaneous Squamous Cell Carcinoma (cSCC)
Keytruda Is Now Approved for the Treatment of Patients With Recurrent or Metastatic or Locally Advanced cSCC That Is Not Curable by Surgery or Radiation KENILWORTH, N.J.--(BUSINESS WIRE) July 6, 2021 -- Merck (NYSE: MRK), known as MSD... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 6, 2021 Category: Drugs & Pharmacology Source Type: news

Melanoma registry results shine light on rare pediatric cancer
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital scientists created a registry for molecular analysis of pediatric melanoma that provides insight into treatment. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 6, 2021 Category: Biology Source Type: news

Experts say you should wear sunglasses all day from March to September
Research by the Australian Skin Cancer Foundation found that eyes are ten times more sensitive to the sun's invisible ultraviolet (UV) rays than skin. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2021 Category: Consumer Health News Source Type: news

The Big Number: Sunburn and the dangers of skin cancer
Overexposure to ultraviolet rays not only accelerates the aging of your skin but also increases your risk for skin cancer — including melanoma, the deadliest type. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - July 4, 2021 Category: Consumer Health News Authors: Linda Searing Source Type: news

Consumer Health: UV radiation and your skin
July is UV Safety Month, which makes this a good time to learn more about the harmful effects of ultraviolet, or UV, radiation from sunlight or tanning beds. Skin cancer is the most common type of cancer, according to the American Cancer Society. Skin cancer develops primarily on areas of sun-exposed skin, including the scalp, face, lips, ears, neck, chest, arms, hands and legs.  The three main types of skin cancer are basal cell carcinoma, squamous cell carcinoma and melanoma.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 4, 2021 Category: Databases & Libraries Source Type: news

Shining a Light on Sunscreens: Using Sunscreen Every Day Could Reduce Your Risk of Skin Cancer
SATURDAY, July 3, 2021 -- Sunscreen isn't just for pool gatherings and beach outings: Using sunscreen every day could reduce your risk of skin cancer, experts say. Daily use of at least an SPF 15 sunscreen can lower your risk of melanoma—... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 3, 2021 Category: General Medicine Source Type: news

Shining a Light on Sunscreens
SATURDAY, July 3, 2021 -- Sunscreen isn't just for pool gatherings and beach outings: Using sunscreen every day could reduce your risk of skin cancer, experts say. Daily use of at least an SPF 15 sunscreen can lower your risk of melanoma — the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 3, 2021 Category: General Medicine Source Type: news

Science Saturday: Melanoma test to help some patients avoid surgical biopsy
More than 100,00 people in the U.S. are expected to be diagnosed with melanoma this year — double the number of cases compared to 30 years ago, according to the American Academy of Dermatology Association.  "Melanoma accounts for only about 2% of skin cancers, but it causes a majority of skin cancer deaths," says Alexander Meves, M.D., a Mayo Clinic dermatologist whose laboratory in Mayo Clinic's Center for Individualized Medicine works on cutting-edge methods to diagnose and treat melanoma.… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - July 3, 2021 Category: Research Source Type: news

Mayo Clinic Q and A: Bleeding moles and skin checks
DEAR MAYO CLINIC: I have a significant number of moles. While most do not bother me, I have at least one that bleeds from time to time. Should I see my doctor for a mole that bleeds? ANSWER: Moles are groups of pigment cells, and nearly everyone has them. Most moles are harmless, but it's possible for melanoma — a rare but serious skin cancer — to develop in or near a mole. Although it may not… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 2, 2021 Category: Databases & Libraries Source Type: news

NIVO + LAG-3 Antibody Succeeds in Advanced Melanoma NIVO + LAG-3 Antibody Succeeds in Advanced Melanoma
ASCO studies validate dual LAG-3 and PD-1 inhibition in advanced melanoma, with good tolerability profiles, says Jeffrey Weber.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 1, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Is YOUR mole dangerous? 9 things to check to avoid skin cancer
MOLES are usually nothing to worry about unless they change size, shape or colour. Is YOUR mole dangerous? (Source: Daily Express - Health)
Source: Daily Express - Health - July 1, 2021 Category: Consumer Health News Source Type: news

Consumer Health: The importance of sunscreen, sunglasses and protective clothing for adults and children
July is UV Safety Month, which makes this a good time to learn more about protecting yourself and your family from the harmful effects of ultraviolet, or UV, radiation from sunlight. Exposure to UV radiation from the sun damages your skin, and increases your risk of developing skin cancer, wrinkles and age spots. Children are especially vulnerable because they tend to spend more time outdoors and can burn easily. Here are four ways you can… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 1, 2021 Category: Databases & Libraries Source Type: news

AC Feels Great, But It ’s Terrible for the Planet. Here’s How to Fix That
For the past few days, a heatwave has glowered over the Pacific Northwest, forcing temperatures in the region to a record-breaking 118ºF. Few people in the region—neither Americans nor Canadians—have air-conditioning. Stores sold out of new AC units in hours as a panicked public sought a reasonable solution to the emergency. Unfortunately, air-conditioning is part of what’s causing the unusual heatwave in the first place. We came close to destroying all life on Earth during the Cold War, with the threat of nuclear annihilation. But we may have come even closer during the cooling war, when the rising ...
Source: TIME: Science - June 30, 2021 Category: Science Authors: Eric Dean Wilson Tags: Uncategorized Source Type: news

Looking at tumors through a new lens
(Institute for Systems Biology) Neoadjuvant immune checkpoint blockade is a promising treatment for melanoma and other cancer types, and has recently been shown to provide a modest survival benefit for patients with recurrent glioblastoma. To improve the treatment efficacy, researchers are looking for vulnerabilities in surgically removed glioblastoma tissues, but this has been difficult due to the vast differences within the tumor and between patients. To address this challenge, ISB researchers and their collaborators developed a new way to study tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2021 Category: International Medicine & Public Health Source Type: news

Cell-based immunotherapy shows promise against melanoma
(Washington University School of Medicine) Researchers at Washington University School of Medicine in St. Louis have shown in preclinical studies conducted in mice and human cells that a type of immunotherapy based on natural killer cells could be effective against solid tumors, starting with melanoma, a type of skin cancer that can be deadly if not caught early. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2021 Category: International Medicine & Public Health Source Type: news

EORTC and Pierre Fabre partner to address treatment gap for stage 2 melanoma patients
(European Organisation for Research and Treatment of Cancer) European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients with resected Stage 2 BRAF-mutant melanoma. The partnership includes the planning, design and execution of a large Phase 3 study investigating the use of BRAF and MEK targeted therapies to reduce the risk of relapse in this patient population, currently under approval with authorities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news

Doctor Empathy After'the Bottom Drops Out of Your World'Doctor Empathy After'the Bottom Drops Out of Your World '
A book about surviving stage IV melanoma highlights the importance of the patient-doctor relationship and, in particular, empathy – and the lack of it.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 25, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

“Lemon Frost” Leopard Geckos’ Cancers Similar to Human Melanomas
The color morph ’s bright yellow hue and its propensity for skin tumors both likely stem from a gene implicated in a dangerous form of human skin cancer, suggesting the animals could make an ideal... (Source: The Scientist)
Source: The Scientist - June 24, 2021 Category: Science Tags: News & Opinion Source Type: news

Leopard gecko skin tumors traced to cancer gene
(Howard Hughes Medical Institute) In a rare gecko color variety known as Lemon Frost, scientists have traced an unusual coloring and tendency to form tumors to a gene linked to human melanoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2021 Category: Cancer & Oncology Source Type: news

Common moles could serve as players in battling melanoma and preventing its recurrence
(Massachusetts General Hospital) The road to an effective melanoma prevention and treatment could involve suppressing Tregs, immune cells that block the activity of CD4+ T cells in moles. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 23, 2021 Category: Cancer & Oncology Source Type: news

Poll: Many ‘ High - Risk ’ Americans Unconcerned About Skin Cancer
AAD survey revealed that 49 percent of respondents were more worried about avoiding sunburn than preventing skin cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 22, 2021 Category: Cancer & Oncology Tags: Dermatology, Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pharmacy, Institutional, Source Type: news